发明名称 Substituted Thiazoleacetic Acid as Crth2 Ligands
摘要 Compounds of formula (I) are useful for the treatment of disease responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis; wherein X<SUB>1 </SUB>is -S-, -O-, -N-N-. -NR<SUB>7</SUB>-, -CR<SUB>7</SUB>-CR<SUB>8</SUB>-, -CR<SUB>7</SUB>-N-, wherein R<SUB>7 </SUB>and R<SUB>8 </SUB>are independently hydrogen or C<SUB>1</SUB>-C<SUB>3 </SUB>alkyl; A is a carboxyl group -COOH, or a carboxyl bioisostere; rings Ar<SUP>2 </SUP>and Ar<SUP>3 </SUP>each independently represent a phenyl or 5- or 6-membered monocyclic heteroaryl ring, or a bicyclic ring system consisting of a 5- or 6-membered carbocyclic or heterocyclic ring which is benz-fused or fused to a 5- or 6-membered monocyclic heteroaryl ring, said ring or ring system being optionally substituted; ring B is as defined for Ar<SUP>2 </SUP>and Ar<SUP>3</SUP>, or an optionally substituted N-pyrrolidinyl, N-piperidinyl or N-azepinyl ring; s is 0 or 1; L1, L2 and L4 are linker radicals as defined in the description; Q<SUB>1 </SUB>and Q<SUB>2 </SUB>represent substituents as defined in the description.
申请公布号 US2008119456(A1) 申请公布日期 2008.05.22
申请号 US20070597839 申请日期 2007.09.14
申请人 ULVEN TROND;FRIMURER THOMAS;RIST OYSTEIN;KOSTENIS EVI;HOGBERG THOMAS;RECEVEUR JEAN-MARIE;GRIMSTRUP MARIE 发明人 ULVEN TROND;FRIMURER THOMAS;RIST OYSTEIN;KOSTENIS EVI;HOGBERG THOMAS;RECEVEUR JEAN-MARIE;GRIMSTRUP MARIE
分类号 A61K31/53;A61K31/506;A61K31/55;C07D277/30;C07D403/02;C07D413/02;C07D417/02;C07D417/04;C07D417/06 主分类号 A61K31/53
代理机构 代理人
主权项
地址